State Street Interest Paid decreased by 11.6% to $1.78B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 14.0%, from $2.07B to $1.78B. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 292.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $9.25M | $9.25M | $9.25M | $338.50M | $338.50M | $338.50M | $338.50M | $1.55B | $1.55B | $1.55B | $1.55B | $1.99B | $2.21B | $2.39B | $2.36B | $2.07B | $2.41B | $2.31B | $2.02B | $1.78B |
| QoQ Change | — | +0.0% | +0.0% | >999% | +0.0% | +0.0% | +0.0% | +356.7% | +0.0% | +0.0% | +0.0% | +28.7% | +11.1% | +8.3% | -1.5% | -12.0% | +16.0% | -4.2% | -12.4% | -11.6% |
| YoY Change | — | — | — | — | >999% | >999% | >999% | +356.7% | +356.7% | +356.7% | +356.7% | +28.7% | +42.9% | +54.9% | +52.5% | +4.3% | +8.9% | -3.7% | -14.4% | -14.0% |